Pharmagenus is the specific business unit within the Uriach Group, for developing its activity in the GE (General Equivalent) sector. Founded in 1997, this division was created just when Generic Medicines started to be implemented in Spain.
With this division, the Uriach Group has responded to the increasingly greater demand for Generic Medicines in Spain. The current and future production of generic medicines seeks to respond to the public interest and need, through production based on the highest quality standards.
Pharmagenus is today a solvent division with promising future projection.
In the next decade, Pharmagenus will continue to base its strategy on innovative development. To do this, we can count on the drive and ambition of the whole Uriach team.